Keeping Track Of Immuno-Oncology: An Updated Guide To Applications At FDA
Executive Summary
Infographic highlights products in the burgeoning PD-1/L1 checkpoint inhibitor class either approved or under review, from the Pink Sheet's FDA Performance Tracker.